PO.MCB03.02 · 分子与细胞生物学
DDR1胞外域脱落在胶质母细胞瘤放疗抵抗中的作用
The role of DDR1 ectodomain shedding in glioblastoma radiation resistance
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
引言:胶质母细胞瘤(GBM)是成人最常见的恶性脑肿瘤,对放射治疗的抵抗仍是主要的治疗障碍。尽管遗传学改变促进GBM进展,但它们并不能完全解释放疗抵抗的出现,提示存在非遗传机制的贡献。值得注意的是,放疗抵抗性GBM表现出胶原沉积升高。盘状结构域受体酪氨酸激酶1(DDR1)是一种受胞外域脱落调控的胶原结合受体,在GBM中高表达。在此,我们证明放疗抵抗性GBM响应胶原改变DDR1的活性和脱落,以促进肿瘤细胞增殖。
方法与结果:为研究DDR1的调控,我们利用了一对GBM患者来源的异种移植细胞系JX39P(放疗敏感)和JX39P-RT(放疗抵抗)。JX39P-RT表现出显著更高的DDR1 mRNA和蛋白表达。当细胞包埋于I型胶原以模拟细胞外环境时,JX39P-RT中DDR1在Y792位点的磷酸化比JX39P更迅速、程度更高。胶原包埋还导致JX39P-RT中一个短DDR1片段的累积,表明胞外域脱落增强。条件培养基的Western印迹证实DDR1 N端片段释放增加,并证实胞外域脱落仅在JX39P-RT中响应胶原发生。用广谱MMP抑制剂marimastat处理JX39P-RT细胞,减少了培养基中脱落的N端片段和细胞裂解物中的短C端片段。与DDR1表达和激活升高一致,JX39P-RT包埋于I型胶原时表现出磷酸化ERK1/2水平升高,表明下游信号通路增强。此外,细胞增殖检测和Ki67染色显示,在液体培养中JX39P细胞比JX39P-RT增殖更快;然而,包埋于I型胶原时,JX39P的Ki67染色无显著变化,而JX39P-RT则表现出时间依赖性升高,表明放疗抵抗性GBM细胞响应胶原和DDR1介导的信号发生增殖。
结论:总之,我们的结果确定DDR1上调和胞外域脱落是促进放疗抵抗性GBM细胞增殖和存活的关键适应性机制。这些调控过程使抵抗性细胞在治疗压力下维持生长,提供了一种潜在的治疗逃逸机制。未来研究将探究DDR1脱落与下游信号如何整合以维持放疗抵抗,并探索使GBM对放疗增敏的策略。
查看英文原文 English abstract
Introduction: Glioblastoma (GBM) is the most common malignant brain tumor in adults, and resistance to radiation therapy remains a major therapeutic obstacle. Although genetic alterations contribute to GBM progression, they do not fully explain the emergence of radiation resistance, suggesting contributions from non-genetic mechanisms. Notably, radiation-resistant GBM exhibits elevated collagen deposition. Discoidin domain receptor tyrosine kinase 1 (DDR1), a collagen-binding receptor regulated by ectodomain shedding, is highly expressed in GBM. Here, we demonstrate that radiation-resistant GBM alters DDR1 activity and shedding in response to collagen to promote tumor cell proliferation.
Methods and Results: To investigate DDR1 regulation, we utilized a GBM patient-derived xenoline pair, JX39P (radiation-sensitive) and JX39P-RT (radiation-resistant). JX39P-RT displayed significantly higher DDR1 mRNA and protein expression. When cells were embedded in collagen I to mimic the extracellular environment, DDR1 phosphorylation at Y792 increased more rapidly and to a greater extent in JX39P-RT than in JX39P. Collagen embedment also led to the accumulation of a short DDR1 fragment in JX39P-RT, indicating enhanced ectodomain shedding. Western blotting of conditioned media confirmed increased release of the DDR1 N-terminal fragment and confirmed that ectodomain shedding occurred only in JX39P-RT in response to collagen. Treatment of JX39P-RT cells with marimastat, a broad-spectrum MMP inhibitor, diminished both the N-terminal fragment shed in the media and the short C-terminal fragment in cell lysates. Consistent with elevated DDR1 expression and activation, JX39P-RT exhibited increased phospho-ERK1/2 levels when embedded in collagen I, indicating enhanced downstream signaling pathways. Furthermore, cell proliferation assays and Ki67 staining showed that JX39P cells proliferate more rapidly than JX39P-RT in liquid culture; however, when embedded in collagen I, JX39P showed no significant change in Ki67 staining, whereas JX39P-RT demonstrated a time-dependent increase, indicating that radiation-resistant GBM cells proliferate in response to collagen- and DDR1-mediated signaling.
Conclusions: Together, our results identify DDR1 upregulation and ectodomain shedding as key adaptive mechanisms that promote proliferation and survival of radiation-resistant GBM cells. These regulatory processes enable resistant cells to sustain growth under therapeutic stress, providing a potential mechanism of therapeutic evasion. Future studies will investigate how DDR1 shedding and downstream signaling integrate to maintain radiation resistance and explore strategies to sensitize GBM to radiation therapy.
利益披露 Disclosure
S. Dunlap, None..
C. A. Harvey, None..
A. Erin, None.